Higher doses of tisagenlecleucel are associated with improved outcomes: a report from the pediatric real-world CAR consortium
Sign Up to like & getrecommendations! Published in 2022 at "Blood Advances"
DOI: 10.1182/bloodadvances.2022007246
Abstract: Key Points • Currently, patients receive a single dose of tisagenlecleucel across a wide dose range.• Clinicians could choose to give a higher dose of tisagenlecleucel upfront, within the approved dose range, to optimize response. read more here.
Keywords: doses tisagenlecleucel; improved outcomes; higher doses; tisagenlecleucel associated ... See more keywords